Plasma hormones in patients with advanced breast cancer treated with tamoxifen
- 1 September 1976
- journal article
- research article
- Published by Elsevier in European Journal of Cancer (1965)
- Vol. 12 (9), 719-723
- https://doi.org/10.1016/0014-2964(76)90022-0
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- The effect of synthetic anti-oestrogens on the growth and biochemistry of rat mammary tumoursEuropean Journal of Cancer (1965), 1975
- INHIBITION OF OESTROGEN-STIMULATED PROLACTIN RELEASE BY ANTI-OESTROGENSJournal of Endocrinology, 1975
- Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptorEuropean Journal of Cancer (1965), 1975
- Basal prolactin blood levels in three strains of rat with differing incidence of 7,12-Dimethylbenz (a) anthracene induced mammary tumoursEuropean Journal of Cancer (1965), 1973
- Plasma prolactin in breast cancerEuropean Journal of Cancer (1965), 1973
- Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose LevelsBMJ, 1973
- Radioimmunoassay for Human Pituitary Prolactin, Using Antiserum against an Extract of Human Amniotic FluidHormone Research, 1973
- A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474British Journal of Cancer, 1971
- THE SECRETION OF IMMUNO-REACTIVE LUTEINIZING HORMONE AND FOLLICLE-STIMULATING HORMONE BY THE HUMAN FOETAL PITUITARY IN ORGAN CULTUREJournal of Endocrinology, 1971
- ABNORMAL URINARY STEROID EXCRETION AND SUBSEQUENT BREAST CANCER: A Prospective Study in the Island of GuernseyThe Lancet, 1967